Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice

Japanese Journal of Cancer Research

Volumn 88, Issue 12, 1997, Pages 1117-1120

  Nakatsugi, Seiichi ^a,b   Fukutake, Masato ^a   Takahashi, Mami ^a   Fukuda, Kazunori ^a   Isoi, Takashi ^b   Taniguchi, Yasuaki ^c   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b SAWAI PHARMACEUTICAL CO LTD   (Japan)

^c HISAMITSU PHARMACEUTICAL CO INC   (Japan)

Author keywords

COX 2 inhibitor; Intestinal polyp; Min mouse; Nimesulide

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NIMESULIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; FEMALE; INTESTINE POLYP; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031460715     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00337.x     Document Type: Article

References (25)

1. Thun, M. J., Namboodiri, M. M. and Heath, C. W., Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325, 1593-1596 (1991).
2. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V. and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55, 1464-1472 (1995).
3. Reddy, B. S., Tokumo, K., Kulkarni, N., Aligia, C. and Kelloff, G. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis, 13, 1019-1023 (1992).
4. Kinzler, K. W., Nilbert, M. C, Su, L. K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., Finniear, R., Markham, A., Groffen, J., Boguski, M. S., Altschul, S. F., Horii, A., Ando, H., Miyoshi, Y., Miki, Y., Nishisho, I. and Nakamura, Y. Identification of FAP locus genes from chromosome 5q21. Science, 253, 661-665 (1991).
5. Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S. and Hedge, P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253, 665-669 (1991).
6. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R. and Offerhaus, G. J. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316 (1993).
7. Hirata, K., Itoh, H. and Ohsato, K. Regression of rectal polyps by indomethacin suppository in familial adenomatous polyposis. Report of two cases. Dis. Colon Rectum, 37, 943-946 (1994).
8. Su, L. K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A. and Dove, W. F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668-670 (1992).
9. Shoemaker, A. R., Gould, K. A., Luongo, C., Moser, A. R. and Dove, W. F. Studies of neoplasia in the Min mouse. Biochim. Biophys. Acta, 1332, F25-F48 (1997).
10. Beazer-Barclay, Y., Levy, D. B., Moser, A. R., Dove, W. F., Hamilton, S. R., Vogelstein, B. and Kinzler, K. W. Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis, 17, 1757-1760 (1996).
11. Boolbol, S. K., Dannenberg, A. J., Chadburn, A., Martucci, C., Guo, X. J., Ramonetti, J. T., Abreu-Goris, M., Newmark, H. L., Lipkin, M. L., DeCosse, J. J. and Bertagnolli, M. M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56, 2556-2560 (1996).
12. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 56, 710-714 (1996).
13. Herschman, H. R. Prostaglandin synthase 2. Biochim. Biophys. Acta, 1299, 125-140 (1996).
14. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S. and Dubois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188 (1994).
15. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789 (1995).
16. DuBois, R. N., Radhika, A., Reddy, B. S. and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110, 1259-1262 (1996).
17. Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D. and DuBois, R. N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111, 1134-1140 (1996).
18. 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809 (1996).
19. Tsujii, M. and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501 (1995).
20. Meade, E. A., Smith, W. L. and DeWitt, D. L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem., 268, 6610-6614 (1993).
21. Weissenbach, R. Clinical trial with nimesulide, a new non-steroid anti-inflammatory agent, in rheumatic pathology. J. Int. Med. Res., 9, 349-352 (1981).
22. Nakatsugi, S., Terada, N., Yoshimura, T., Horie, Y. and Furukawa, M. Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress induced gastric lesions in rats. Prostaglandins Leukot. Essent. Fatty Acids, 55, 395-402 (1996).
23. Taniguchi, Y., Ikesue, A., Yokoyama, K., Noda, K., Debuchi, H., Nakamura, T., Toda, A. and Shimeno, H. Selective inhibition by nimesulide, a novel non-steroidal anti-inflammatory drug, with prostaglandin endoperoxide synthase-2 activity in-vitro. Pharm. Sci., 1, 173-175 (1995).
24. Takahashi, M., Fukutake, M., Yokota, S., Ishida, K., Wakabayashi, K. and Sugimura, T. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase-2. J. Cancer Res. Clin. Oncol., 166, 219-222 (1996).
25. Cipollini, F., Mecozzi, V. and Altilia, F. Endoscopic assessment of the effects of nimesulide on the gastric mucosa: comparison with indomethacin. Curr. Ther. Res., 45, 1042-1048 (1989).